PRME Competitors & Alternatives
Compare Prime Medicine, Inc. Common Stock with similar stocks in the same industry
Biotechnology
PRME
Main Stock$2.79
Tradestie Score
42
Market Cap
$996.55M
Revenue Growth
-0.4%
Analyst Upside
+147.9%
Top Competitors
228 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ERAS
Erasca, Inc. Common Stock
|
$10.13
|
$626.91M | - | 49 | Compare |
|
SVRA
Savara Inc.
|
$5.01
|
$611.84M | - | 54 | Compare |
|
KALV
KalVista Pharmaceuticals, Inc. Common Stock
|
$26.73
|
$608.81M | - | 59 | Compare |
|
CTMX
CytomX Therapeutics, Inc.
|
$3.47
|
$552.46M | - | 45 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$11.94
|
$540.97M | - | 55 | Compare |
|
PRTA
Prothena Corporation plc Ordinary Shares
|
$9.67
|
$533.99M | - | 55 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$10.58
|
$529.35M | 5.8 | 57 | Compare |
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$2.11
|
$512.39M | - | 62 | Compare |
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$28.40
|
$505.12M | 1.7 | 58 | Compare |
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$104.10
|
$492.21M | - | 55 | Compare |
More PRME Analysis
Data updated: May 18, 2026 | Industry: Biotechnology (SIC 2836)
228 stocks in this industry